KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Tenet Healthcare (THC) Cost of Revenue (2016 - 2025)

Tenet Healthcare's Cost of Revenue history spans 17 years, with the latest figure at $1.1 billion for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 0.72% year-over-year to $1.1 billion; the TTM value through Sep 2025 reached $4.9 billion, up 13.08%, while the annual FY2025 figure was $3.8 billion, 15.85% down from the prior year.
  • Cost of Revenue for Q3 2025 was $1.1 billion at Tenet Healthcare, up from $907.0 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $1.8 billion in Q4 2024 and bottomed at $643.0 million in Q4 2021.
  • The 5-year median for Cost of Revenue is $974.5 million (2022), against an average of $1.0 billion.
  • The largest annual shift saw Cost of Revenue soared 993.06% in 2021 before it plummeted 41.26% in 2023.
  • A 5-year view of Cost of Revenue shows it stood at $643.0 million in 2021, then surged by 146.5% to $1.6 billion in 2022, then tumbled by 41.26% to $931.0 million in 2023, then skyrocketed by 90.66% to $1.8 billion in 2024, then tumbled by 36.96% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for THC's Cost of Revenue are $1.1 billion (Q3 2025), $907.0 million (Q1 2025), and $1.8 billion (Q4 2024).